Stock screener

PVLA

Conviction 80HealthcareScan · Mon, Aug 10, 2026
PVLA$152.22-3.52%
ResistanceSupportVol 14Insider sell
63 bars
4
3
3
Vol MA14 156.2K
May 11May 28Jun 16Jul 6Jul 23Aug 10
PALVELLA THERAPEUTICS, INC.PHARMACEUTICAL PREPARATIONSwww.palvellatx.com
Price152.22
Change-3.52%
Gap-1.43%
Rel volume0.35×
Avg volume203.56K
Avg $ vol29.39M
SMA 20146.36
SMA 50133.97
SMA 200111.81
Price vs 50+13.62%
Price vs 200+36.14%
MA stackbullish
50/200 cross
Supertrenddown · 158.04
RSI (14)55
MACD hist0.55
MACD crossbull · 3d
Stoch %K / %D67 / 82
ADX (14)17
+DI / −DI21 / 18
RSI divergence
MACD divergenceBearish
ATR %+6.44%
ADR %7.35%
52w high157.77
52w low40.90
From 52w high-3.52%
Above 52w low+272.18%
New 52w highNo
SqueezeOff
Bollinger width21.60%
%B0.69
Donchian pos79.30%
Donchian high160.47
Donchian low120.61
AVWAP (52w high)145.23
vs AVWAP high+4.81%
AVWAP (52w low)105.33
vs AVWAP low+44.52%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d0.35×
Avg vol (14d)156.2K
Avg vol (20d)203.56K
Avg $ vol (20d)29.39M
Market cap
RS 3m (vs SPY)+33.60%
RS 6m (vs SPY)+92.31%
RS line new highNo
Trend template8/8
Technical rank84.2
1 week+8.13%
1 month+5.15%
3 months+25.50%
6 months+85.18%
1 year+289.81%
YTD+51.79%
P/E-54.40
P/B10.46
P/S52.00
P/FCF-90.14
EPS-3.71
Div yield
ROE-19.24%
ROA-16.46%
Debt/Eq
Current21.18
EV/EBITDA-56.72
Gross margin
Net margin-95.58%
Rev growth60.18%
EPS growth-139.27%
Price target232.67
Target upside47.72%
Analyst ratingBuy
Institutional102.34%
Ent. value2.08B
Revenue14.5M
Net income-21.87M
Gross profit
Free cash flow-25.18M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out14.34M
Employees29
ListedMon, Dec 16, 2024
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA
Conviction80 / 100
Pattern quality
Tech rank84.2 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance160.93
Support127.80
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PVLA

All disclosures →
No recent disclosed trades by Congress in PVLA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PVLA · 4 buys · 6 sells

InsiderSideShares
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-07-15
Exercise2.15K
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-07-15
Exercise2.15K
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-07-15
Sell522
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-07-15
Sell840
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-07-15
Sell1.03K
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-07-15
Sell1.91K
Goin Kathleen
Chief Operating Officer · Stock Option (Right to Buy) · 2026-07-15
Exercise2.15K
Goin Kathleen
Chief Operating Officer · Stock Option (Right to Buy) · 2026-07-15
Exercise2.15K
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-06-17
Exercise2.15K
Goin Kathleen
Chief Operating Officer · Common Stock · 2026-06-17
Exercise2.15K

SEC filings

EDGAR filings in PVLA · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.